Growth · Research reference

CJC + Ipa

GHRH analog + selective ghrelin agonist. Co-formulated CJC-1295 (no DAC) + Ipamorelin. Researched for synergistic GH-pulse amplification with minimal cortisol or prolactin involvement.

See the wiki entry

Half-life

~30 min CJC / ~2 hr Ipa (SC)

Molar mass

3367.9 / 711.85 g/mol

Purity floor

≥99%

CAS

863288-34-0 / 170851-70-4

Mechanism

CJC-1295 is a synthetic GHRH analog that binds the GHRH receptor on pituitary somatotrophs; Ipamorelin is a selective GHSR (ghrelin receptor) agonist. Together in vitro they activate complementary growth-hormone-secretion pathways without significant ACTH/cortisol/prolactin cross-activation.

Common in-vitro applications

GHRH-receptor activation
cAMP accumulation in HEK293 cells expressing recombinant GHRH-R.
Working range: nM range
GHSR selectivity profiling
Comparative receptor-binding panels vs other ghrelin-receptor agonists.
Working range: nM range

Reconstitution + storage

Reconstitution

2ml bacteriostatic water → 5mg/ml

Per-vial mass

10mg

Lyophilized storage

−20°C or below, desiccated

Reconstituted storage

2–8°C, use within 30 days

Light + air

Protect from light and air

Solubility

Soluble in bacteriostatic water (0.9% benzyl alcohol)

Background: lyophilization · reconstitution

Co-treatment partners

MK-677 (Ibutamoren)
Orally-active GHSR agonist comparator.
Sermorelin
Shorter-half-life GHRH analog comparator.

Selected peer-reviewed citations

Teichman SL, et al. (2006). Prolonged stimulation of GH and IGF-I secretion by CJC-1295. Journal of Clinical Endocrinology & Metabolism.
Raun K, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology.

Verification

Read the COA

Open the batch lookup — Janoshik HPLC-UV + ESI-MS packet.

Open

Buy this kit

CJC + Ipa · $75

Lyophilized, COA-verified, tracked US shipping.

Open the PDP

Reference data is supplied for in-vitro literature context only. Aurex does not provide dosage or use guidance — Federal regulations governing research-chemical distribution prohibit it. CJC + Ipa is sold for in-vitro research applications only, by qualified researchers. Not for human or veterinary use. Not FDA approved.